Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Bullboard Posts
Post by metalbrainon Feb 10, 2012 4:34pm
437 Views
Post# 19518409

Not Selling Till $5

Not Selling Till $5

There's no need to pump this play since the technology speaks for itself - no matter what one's dermatologist says lol.  Sure $60 grand is a lot of money for the Aura, but in the big picture it's a very small price to pay for saving lives and huge health care costs.  Big medical companies could probably crank the Aura out for $30 grand and you can bet that they've already tallied up the numbers with a big grin.   However for now they are all too happy to sit back and wait for Verisante to do all the work before FDA approval.  My timeframe is between 1 to 2 years, until then the sp will most likely frustrate most here.  That being said I also believe that there are a few triggers that could set the sp on fire before then.  One being brisk Aura sales, the continued progression of the Core and another being a big investor that's willing to take out the asks.  Imo the low volume must be frustrating for large investors, however they're patient as well, but than again the low outstanding shares will leave out many.  Ah yes the waiting game lol.  

Those that cannot see the writing on the wall here are either too lazy to do their own dd, but most likey are just bashing imo.

 

GLTA!

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse